Alpharma Inc. (ALO) is breaking out on the news of they have agreed to sell its U.S. and International Generics businesses to Actavis Group for $810 million.
ALO Alert
Alpharma Inc. (ALO) is breaking out on the news of they have agreed to sell its U.S. and International Generics businesses to Actavis Group for $810 million.
